An **Autoimmune Encephalitis Panel-2 CSF** is an advanced diagnostic panel performed on cerebrospinal fluid (CSF) to evaluate acute central nervous system inflammation caused by specific autoantibodies. By analyzing CSF directly—where neural antibody concentrations are often highest and most specific—this test screens for target antibodies targeting cell-surface and intracellular neuronal antigens, including NMDAR, LGI1, CASPR2, and GAD65.
This panel is vital for differentiating autoimmune-mediated neurological disorders from infectious or metabolic encephalopathies. Detecting these antibodies directly from CSF provides high diagnostic precision, enabling neurologists to rapidly initiate targeted immunotherapies, suppress brain inflammation, and optimize patient recovery.